High‐dose intranasal insulin in an adaptive dose‐escalation study in healthy human participants
Abstract Intranasal insulin is a putative neuroprotective therapy after cardiac arrest, but safety in humans at doses extrapolated from animal models is unknown. This phase I, open‐label adaptive dose‐escalation study explores the maximum tolerated dose of intranasal insulin in healthy human partici...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2024-11-01
|
| Seri Bilgileri: | Clinical and Translational Science |
| Online Erişim: | https://doi.org/10.1111/cts.70071 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|